Matches in DBpedia 2016-04 for { ?s ?p "ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma.In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.[R]-ICE regimen consists of: (R)ituximab - an anti-CD20 monoclonal antibody, which is able to kill both normal and malignant CD20-bearing B cells; (I)fosfamide - an alkylating antineoplastic agent of the oxazafosforine group; (C)arboplatin - a platinum based drug, also with an alkylating mechanism; (E)toposide - a topoisomerase inhibitor."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- ICE_(chemotherapy) abstract "ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma.In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.[R]-ICE regimen consists of: (R)ituximab - an anti-CD20 monoclonal antibody, which is able to kill both normal and malignant CD20-bearing B cells; (I)fosfamide - an alkylating antineoplastic agent of the oxazafosforine group; (C)arboplatin - a platinum based drug, also with an alkylating mechanism; (E)toposide - a topoisomerase inhibitor.".
- Q5969522 abstract "ICE in the context of chemotherapy is an acronym for one of the chemotherapy regimens, used in salvage treatment of relapsed or refractory non-Hodgkin's lymphoma and Hodgkin lymphoma.In case of CD20-positive B cell lymphoid malignancies the ICE regimen is often combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE.[R]-ICE regimen consists of: (R)ituximab - an anti-CD20 monoclonal antibody, which is able to kill both normal and malignant CD20-bearing B cells; (I)fosfamide - an alkylating antineoplastic agent of the oxazafosforine group; (C)arboplatin - a platinum based drug, also with an alkylating mechanism; (E)toposide - a topoisomerase inhibitor.".